COVID-19 Situation Report 24/06/2021
Note: This report is a current snapshot and is updated on a weekly base. 6
Figure 4: Weekly number of newly hospitalised SARI cases (ICD-10 codes J09-J22) and proportion of cases with a diagnosis of COVID- 19 (ICD-10 code U07.1!) among SARI cases with date of admission in weeks 12, 2020 to 24, 2021. Data are derived from 72 sentinel hospitals.
Risk Assessment by the RKI
In view of the, despite the recent decrease in case numbers, high case numbers of COVID-19 and the concerning dynamic of the SARS-CoV-2 variant distribution, the RKI assesses the threat to the health of the general population in Germany to be high. It highlights the ongoing community transmission of SARS-CoV-2 as well as the occurrence of many outbreaks, particularly in households, day-care facilities for children and increasingly in schools, as well as in occupational settings.
In light of the increase in variants of concern (VOC), which have higher infectiousness, a rigorous reduction of physical contacts, use of protective measures, as well as intensive efforts to contain outbreaks and chains of infections are necessary to reduce the number of new infections and to protect people who are
vulnerable.
On 15/06/2021, the risk assessment was updated. The current version can be found through the following link: http://www.rki.de/covid-19-risikobewertung (in German).
COVID-19 Situation Report 24/06/2021
Note: This report is a current snapshot and is updated on a weekly base.
7
Measures taken in Germany
- Current report on variants of concern (VOC) in Germany (23/06/2021, in German) http://www.rki.de/covid-19-voc-berichte
- CovPass-App for digital vaccination report (10.06.2021, in German) https://digitaler-impfnachweis-app.de/
- ControlCOVID – Options and perspectives for a stepwise withdrawal of measures till September 2021 in view of the vaccination campaign (01/06/2021, in German)
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges Coronavirus/ControlCovid Tab.html
- Eight simple tips for daily life during the coronavirus pandemic (in different languages, 17/05/2021) https://www.rki.de/DE/Content/InfAZ/N/Neuartiges Coronavirus/Buerger/Infografik Tipps Alltag.html - Fact box: How safe and effective are COVID-19 mRNA vaccines for adults under the age of 60? (in
different languages, 17/05/2021)
https://www.rki.de/DE/Content/Infekt/Impfen/ImpfungenAZ/COVID-19/Faktenbox-Tab.html - Risk assessment in Germany: http://www.rki.de/covid-19-risikobewertung (01/06/2021, in German) - Information on the designation of international risk areas: http://www.rki.de/covid-19-risikogebiete
(18/06/2021, in German)
- Recommendation for contact management in Germany: www.rki.de/covid-19-kontaktpersonen (20/05/2021, in German)
- Epidemiological profile of SARS-CoV-2 und COVID-19: http://www.rki.de/covid-19-steckbrief (19/04/2021, in German)
- Information about seroepidemiological studies in Germany: www.rki.de/covid-19-serostudies-germany - German electronic Sequencing-Data-Hub (DESH, Deutscher elektronischer Sequenzdaten-Hub, in
German): www.rki.de/covid-19-desh
- Recommendations on COVID-19-vaccination: www.rki.de/covid-19-impfempfehlung (in German) - Government decisions regarding additional containment measures:
https://www.bundesregierung.de/breg-de/themen/coronavirus/mpk-beschluss-corona-1834364 (in German)
- National Test Strategy for SARS-CoV-2 in Germany: www.rki.de/covid-19-teststrategie (in German) - Important information and guidance on SARS-CoV-2 for travellers: www.rki.de/covid-19-reisende
(12/05/2021, in different languages)
- Selected and regularly updated information on COVID-19: https://www.rki.de/covid-19-en - Publication from the Ministry of Health in Germany on measures implemented in Germany :
https://www.bundesgesundheitsministerium.de/coronavirus/chronik-coronavirus.html (in German) - Information from the Ministry of Health in Germany for travellers entering Germany: Frequently asked
questions and answers : https://www.bundesgesundheitsministerium.de/coronavirus-infos- reisende/faq-tests-einreisende.html (in German)
- Corona-Warn-App, the national contact tracing app: www.rki.de/covid-19-warnapp-en
- Information on regional control measure regulations such as physical distancing and quarantine: https://www.bundesregierung.de/breg-de/themen/coronavirus/corona-bundeslaender-1745198 (in German)
COVID-19 Situation Report 24/06/2021
Note: This report is a current snapshot and is updated on a weekly base. 8
Further information sources
- Information on COVID-19 provided the German government in multiple languages (Arabic, Dari, English, Farsi, French, Russian, Turkish): https://www.bundesregierung.de/breg-
de/themen/coronavirus/coronavirus-covid - COVID-19-Dashboard: https://corona.rki.de/ - Miscellaneous data tables:
Case numbers: www.rki.de/covid-19-fallzahlen
Age distribution: www.rki.de/covid-19-altersverteilung
Clinical aspects: www.rki.de/covid-19-tabelle-klinische-aspekte
Number of cases linked to outbreaks: www.rki.de/covid-19-ausbruchsdaten Nowcasting: www.rki.de/covid-19-nowcasting
- Situation reports on COVID-19 for Germany: www.rki.de/covid-19-situationsbericht - Information on vaccinations in Germany:
http://www.rki.de/covid-19-impfquoten https://impfdashboard.de/
- Intensive care registry: https://www.intensivregister.de
- Reports on SARS-CoV-2 variants in Germany: www.rki.de/covid-19-voc-berichte
Annex
1 The difference to the previous day is based on the date that cases are received by the RKI. Due to delays in data sharing, cases from previous days may be included in today’s numbers.
2 Active cases were calculated from the number of shared cases minus deaths and the estimated number of recovered cases.
3 The algorithm for estimating recovered cases takes into account information on disease onset and hospitalisation, but does not do so for late effects since these data are not recorded regularly.
4The number of persons vaccinated once at least once includes all individuals who have received at least one dose of the BioNTech, Moderna, AstraZeneca, or Janssen vaccines.
5Vaccinated fully means: Vaccinated twice with the AstraZeneca or BioNTech or Moderna vaccines, or once with the Janssen vaccine, or once with any of the available vaccines for those with a prior COVID-19 infection.
